1-9 of 9
Florian Hiemeyer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Population Pharmacokinetics and Exposure-Response Analyses from Phase I-III Studies Support Copanlisib Dose Selection in Relapsed Indolent Non-Hodgkin Lymphoma

Jonathan Moss, Dirk Garmann, Rupert Austin, Florian Hiemeyer, Matthew J. Matasar, Pier Luigi Zinzani, Vita Beckert, Lidia Mongay Soler, Barrett H. Childs, Peter N. Morcos
Journal: Blood
Blood (2022) 140 (Supplement 1): 3629–3631.
https://doi.org/10.1182/blood-2022-162819
Published: 2022
Journal Articles

Duration of Objective Responses for Patients with Indolent Non-Hodgkin Lymphoma Discontinuing Treatment before Progression: Analysis from the Phase III Chronos-3 Trial Comparing Copanlisib Plus Rituximab with Placebo Plus Rituximab

Matthew J. Matasar, Marcelo Capra, Muhit Özcan, Fangfang Lv, Wei Li, Eduardo Yañez, Katya Sapunarova, Tongyu Lin, Jie Jin, Wojciech Jurczak, Aryan Hamed, Ming-Chung Wang, Lidia Mongay Soler, Anjun Cao, Florian Hiemeyer, Barrett H Childs, Yuankai Shi, Pier Luigi Luigi Zinzani
Journal: Blood
Blood (2021) 138 (Supplement 1): 3538.
https://doi.org/10.1182/blood-2021-150873
Published: 2021
Journal Articles

Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma

Martin Dreyling, MD, Panayiotis Panayiotidis, MD, George A Follows, MD PhD, Luigina Mollica, MD FRCPC, PhD, Arnon Nagler, MD MSc, Muhit Özcan, MD, Armando Santoro, Don Stevens, MD, David Trevarthen, MD, Florian Hiemeyer, MSc, Li Liu, PhD, Jose Garcia-Vargas, MD, Barrett H Childs, MD, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1531.
https://doi.org/10.1182/blood-2019-121932
Published: 2019
Journal Articles

Outcomes for Patients with High-Risk Relapsed or Refractory Indolent B-Cell Lymphoma Treated with Copanlisib in the CHRONOS-1 Study

Armando Santoro, MD, Luigina Mollica, MD PhD, Sirpa Leppa, MD Prof, George A Follows, MD PhD, Georg Lenz, Won Seog Kim, MD PhD, Arnon Nagler, MD, Maria Dimou, MD PhD, Judit Demeter, MD PhD Dr. Sci, Massimo Magagnoli, MD, Liana Rodrigues, MD, Oliver Wirtz, MSc, Florian Hiemeyer, MSc, Li Liu, PhD, Karl Koechert, PhD, Jose Garcia-Vargas, MD, Barrett H Childs, MD, Pier Luigi Zinzani, MD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 395.
https://doi.org/10.1182/blood-2018-99-116715
Published: 2018
Journal Articles

Long-Term Efficacy and Safety from the Copanlisib CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma

Martin Dreyling, MD PhD, Armando Santoro, MD, Luigina Mollica, MD PhD, Sirpa Leppä, MD, George A Follows, MD PhD, Georg Lenz, Won Seog Kim, MD PhD, Arnon Nagler, MD, Panayiotis Panayiotidis, MD PhD, Judit Demeter, MD PhD Dr. Sci, Muhit Özcan, Marina Kosinova, MD, Krimo Bouabdallah, MD, Franck Morschhauser, MD, Don Stevens, MD, David Trevarthen, MD, Liana Rodrigues, MD, Florian Hiemeyer, MSc, MingLu Wang, MS, Jose Garcia-Vargas, MD, Barrett H. Childs, MD, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1595.
https://doi.org/10.1182/blood-2018-99-114842
Published: 2018
Journal Articles

Outcomes for Patients with Pre-Existing Diabetes or Hypertension Treated with Copanlisib from the CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma

Pier Luigi Zinzani, MD, Armando Santoro, MD, Luigina Mollica, MD FRCPC, PhD, Sirpa Leppä, MD PhD, George A Follows, MD PhD, Georg Lenz, Won Seog Kim, MD PhD, Arnon Nagler, MD, Panayiotis Panayiotidis, MD PhD, Judit Demeter, MD PhD Dr. Sci, Franck Morschhauser, MD, Liana Rodrigues, MD, John Reeves, PhD MS, Florian Hiemeyer, MSc, Ashok Miriyala, MD, Jose Garcia-Vargas, MD, Barrett H. Childs, MD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1613.
https://doi.org/10.1182/blood-2018-99-117063
Published: 2018
Journal Articles

Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial

Martin Dreyling, MD PhD, Panayiotis Panayiotidis, MD PhD, Miklos Egyed, MD PhD, George Follows, MA, PhD FRCP, FRCPath, BM, BCh, Luigina Mollica, MD PhD, Arnon Nagler, MD, Muhit Ozcan, MD, Armando Santoro, MD, Tatiane Ishida, MD, Cindy Lu, PhD, Florian Hiemeyer, MSc, Jose Garcia-Vargas, MD, Barrett H. Childs, MD, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4053.
https://doi.org/10.1182/blood.V130.Suppl_1.4053.4053
Published: 2017
Journal Articles

Updated Safety and Efficacy from the Copanlisib CHRONOS-1 Trial in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma: Low Incidence of Late-Onset Severe Toxicities

Martin Dreyling, MD PhD, Armando Santoro, MD, Luigina Mollica, MD PhD, Sirpa Leppa, MD, George Follows, MA, PhD FRCP, FRCPath, BM, BCh, Georg Lenz, Won Seog Kim, MD, Ph. D., Arnon Nagler, MD, Panayiotis Panayiotidis, MD PhD, Judit Demeter, MD PhD Dr. Sci, Muhit Ozcan, MD, Marina Kosinova, MD, Krimo Bouabdallah, MD, Franck Morschhauser, MD PhD, Don A Stevens, MD, David Trevarthen, MD, Massimo Magagnoli, MD, Tatiane Ishida, MD, Cindy Lu, PhD, Florian Hiemeyer, MSc, Ashok Miriyala, MD, Jose Garcia-Vargas, MD, Barrett H. Childs, MD, Pier Luigi Zinzani, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2777.
https://doi.org/10.1182/blood.V130.Suppl_1.2777.2777
Published: 2017
Journal Articles

Results of the Mantle Cell Lymphoma Subset from a Phase 2a Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent and Aggressive Lymphoma

David Cunningham, Pier Luigi Zinzani, MD PhD, Sarit E. Assouline, MDMSc, Krimo Bouabdallah, MD, Dominique Bron, MD PhD, Corinne Haioun, MD PhD, Luigina Mollica, MD FRCPC, PhD, Marius Giurescu, MDPhD, Igor Gorbatchevsky, MD, Manoel Neves, MD, Marta M. Lemos, MD, Julia Grunert, PhD, Florian Hiemeyer, PhD, Barrett H. Childs, MD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3935.
https://doi.org/10.1182/blood.V126.23.3935.3935
Published: 2015